A stable blue light bionic spray essence and its preparation method

Abstract

The present application relates to the field of cosmetics, and relates to a stable blue-light bionic spray essence and a preparation method thereof. In terms of mass percentage, the essence includes: an oil phase and an aqueous phase; the oil phase is a microemulsion phase; the oil phase includes: oils, oil-soluble active substances, polyols, emulsifiers and water; the aqueous phase includes: moisturizers, water-soluble active substances and water; the essence presents a blue light state; the essence presents a blue light state, and the essence can be in a spray form; the emulsifier does not include PEG-60 hydrogenated castor oil. In the above technical solution, not only can oil-soluble ingredients be added to the aqueous solution, but the aqueous solution product can also present a blue light state, making the product more high-end and more effective. Furthermore, the above solution of the present application can effectively avoid this problem and realize a product that can stably present a blue light without agglomeration. The above technical solution of the present application has developed a stable, blue-light bionic spray essence.

Description

Technical Field

[0001] The present application relates to the field of cosmetics, and more specifically, to a stable blue-light bionic spray essence and a preparation method thereof. Background Art

[0002] Throughout the history of humankind, despite the passage of time, our love of beauty has remained constant. Cosmetic formulations have also evolved rapidly, starting with water-based products, which now include lotions, toners, softeners, astringents, and essences.

[0003] However, common water-based products are circulated in the market as basic moisturizers. Most of them only contain water-soluble moisturizers and water, without any oil-soluble ingredients, which greatly reduces their effectiveness.

[0004] This greatly limits the application of aqueous products. Summary of the Invention

[0005] The purpose of the embodiments of the present application is to provide a stable blue-light bionic spray essence, which can contain both water-soluble active ingredients and oil-soluble active ingredients, and the essence presents blue light and is in a spray form; while improving the efficacy of water-based cosmetics, it also improves the stability of water-based cosmetics.

[0006] In a first aspect, the present application provides a stable blue light bionic spray essence, which comprises, by mass percentage, an oil phase and a water phase;

[0007] The oil phase is the microemulsion phase;

[0008] The oil phase includes: oil, oil-soluble active ingredients, polyols, emulsifiers and water;

[0009] The aqueous phase includes: humectants, water-soluble active ingredients and water;

[0010] The essence appears in a blue light state; the essence appears in a blue light state, and the essence can be in a spray form; the emulsifier does not include PEG-60 hydrogenated castor oil.

[0011] In the above technical solution, not only can oil-soluble ingredients be added to the aqueous solution, but the aqueous solution product can also present a blue light state, making the product more high-end, more effective, and longer-lasting. Furthermore, in the above technical solution, the oil phase is a microemulsion phase; however, conventional microemulsion technology has a fatal weakness: because the particle size range of the microemulsion phase is in the range of 10-100nm, particles within this range will present blue light under light irradiation, but the nanoparticles within this range are very small, so they are very easy to agglomerate into large particles, causing the blue light of the product to disappear and become an ordinary white emulsion. The above solution of the present application can effectively avoid this problem and realize a product that can stably present a blue light without agglomeration. The above technical solution of the present application has developed a stable, blue-light bionic spray essence. The system has higher simplicity and versatility in operation, better stability, and better universality, and can be well applied to industrial production.

[0012] In other embodiments of the present application, the oil includes at least one of synthetic oil and / or vegetable oil.

[0013] In other embodiments of the present application, the synthetic oil includes at least one of triethylhexanoin, caprylic / capric triglyceride, isohexadecane, isododecane, isononyl isononanoate, or hydrogenated polyisobutene.

[0014] In other embodiments of the present application, the plant oil includes at least one of squalane, cetearyl alcohol, hydrogenated polydecene, stearic acid, meadowfoam seed oil, jojoba seed oil, sunflower seed oil, olive oil, camellia seed oil, scutellaria oil or camellia seed oil.

[0015] In other embodiments of the present application, the emulsifier includes at least one of polyglyceryl-3 diisostearate, polyglyceryl-4 isostearate, polyglyceryl-10 myristate, or PPG-13-decyltetradecyl alcohol polyether-24.

[0016] In other embodiments of the present application, the oil-soluble active ingredients include: at least one of ceramides, astaxanthin, tocopherol, phytosterols, sphingolipids, phytosphingosine, tetraacetylphytosphingosine, glycosphingolipids, stearic acid, lecithin, hydrogenated lecithin, cholesterol, VC-IP, retinol, hydroxypinacolone retinoic acid ester or coenzyme Q-10.

[0017] In other embodiments of the present application, the ceramides include at least one of ceramide EOP, ceramide NP, or ceramide AP.

[0018] In other embodiments of the present application, the polyol includes at least one of glycerin, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90, or dipropylene glycol.

[0019] In other embodiments of the present application, the moisturizer includes at least one of glycerin, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90, or dipropylene glycol.

[0020] In other embodiments of the present application, the water-soluble active ingredient includes at least one of allantoin, dipotassium glycyrrhizate, niacinamide, soluble collagen, recombinant collagen, and polypeptides.

[0021] In other embodiments of the present application, in the oil phase, the mass ratio of the emulsifier to the oil is (2:3) to (1:1).

[0022] In other embodiments of the present application, the proportion of water in the oil phase is 4.47% to 4.5%.

[0023] In other embodiments of the present application, the proportion of the oil-soluble active ingredient in the oil phase is 0.9% to 1.29%.

[0024] In other embodiments of the present application, the proportion of polyols in the oil phase is 67.3% to 70.5%.

[0025] In other embodiments of the present application, the proportion of fat in the oil phase is 13.47% to 14.1%.

[0026] In other embodiments of the present application, the proportion of the emulsifier in the oil phase is 9.4% to 13.5%.

[0027] In other embodiments of the present application, in the oil phase, the mass ratio of oil, oil-soluble active ingredient, polyol, emulsifier and water is: (0.3-0.6): (0.02-0.055): (1.5-3): (0.3-0.6): (0.1-0.2).

[0028] In other embodiments of the present application, the oil phase accounts for 2.22% to 4.455% of the essence in terms of mass percentage.

[0029] In other embodiments of the present application, in the aqueous phase, the mass ratio of the moisturizer to the water-soluble active ingredient is (7-8):1.

[0030] In other embodiments of the present application, the essence comprises, by mass percentage: 2.22% to 4.455% of an oil phase; 2% to 10% of a moisturizer; 0.5% to 1% of a water-soluble active ingredient; and the balance water.

[0031] In a second aspect, the present application provides a method for preparing a stable blue light bionic spray essence, comprising:

[0032] After mixing the various raw materials of the oil phase, heating to 65°C to 85°C to obtain a dissolved oil phase mixed raw material;

[0033] adding water dropwise to the dissolved oil phase mixed raw material to form a microemulsion phase;

[0034] The microemulsion phase is then added to the dissolved aqueous phase mixed materials.

[0035] The preparation method of the present application has higher operational simplicity and versatility, better stability, and better universality, and can be well applied to industrial production.

[0036] In other embodiments of the present application, the preparation of the aqueous phase mixed raw material includes:

[0037] After mixing the various raw materials of the aqueous phase, the mixture is heated to 65°C to 85°C to obtain dissolved aqueous mixed raw materials.

[0038] In other embodiments of the present application, the microemulsion phase is added to the dissolved aqueous phase mixed raw materials, stirred and cooled to room temperature. BRIEF DESCRIPTION OF THE DRAWINGS

[0039] In order to more clearly illustrate the technical solutions of the embodiments of the present application, the following is a brief introduction to the drawings required for use in the embodiments. It should be understood that the following drawings only show certain embodiments of the present application and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other relevant drawings can be obtained based on these drawings without creative work.

[0040] Figure 1 This is a picture of the blue light bionic spray essence paste stability experiment in Example 1;

[0041] Figure 2 This is a picture of the blue light bionic spray essence paste stability experiment in Example 2;

[0042] Figure 3 This is a picture of the blue light bionic spray essence paste stability experiment in Example 3;

[0043] Figure 4 This is a picture of the blue light bionic spray essence paste stability experiment in Example 4;

[0044] Figure 5 This is a picture of the stability test paste of the blue light bionic spray essence in comparative example 1;

[0045] Figure 6 This is a picture of the stability experiment of the blue light bionic spray essence paste in comparative example 2;

[0046] Figure 7 This is a picture of the stability experiment of the blue light bionic spray essence paste in comparative example 2;

[0047] Figure 8 It is a spray comparison diagram of Example 1-4 and Comparative Example 1-2. DETAILED DESCRIPTION

[0048] In order to make the purpose, technical solutions and advantages of the embodiments of the present application clearer, the technical solutions in the embodiments of the present application will be clearly and completely described below. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments.

[0049] Therefore, the following detailed description of the embodiments of the present application is not intended to limit the scope of the present application for protection, but merely represents selected embodiments of the present application. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without making creative efforts are within the scope of protection of this application.

[0050] Microemulsion systems are typically prepared using a system containing PEG-60 hydrogenated castor oil. However, these microemulsions are extremely unstable and require very stringent preparation conditions, making them virtually impossible to replicate using conventional cosmetic manufacturing processes. This significantly limits their industrial applications. The inventors discovered that the addition of PEG-60 hydrogenated castor oil to the microemulsion system results in significant instability, making it extremely difficult to form a microemulsion and even more difficult to produce a blue light. This conventional system has stringent experimental requirements, resulting in poor batch stability and difficulty achieving a blue light-emitting system using the simplest methods. Operational failures are also common, leading to the formation of larger particles in conventional emulsion systems.

[0051] Based on this, the embodiment of the present application provides a stable blue light bionic spray essence, which comprises, by mass percentage, an oil phase and a water phase;

[0052] The oil phase is the microemulsion phase;

[0053] The oil phase includes: oil, oil-soluble active ingredients, polyols, emulsifiers and water;

[0054] The aqueous phase includes: humectants, water-soluble active ingredients and water;

[0055] The essence appears in a blue light state; the essence appears in a blue light state, and the essence can be in a spray form.

[0056] In the above technical solution, not only can oil-soluble ingredients be added to the aqueous solution, but the aqueous solution product can also present a blue light state, making the product more high-end, more effective, and longer-lasting. Furthermore, in the above technical solution, the oil phase is a microemulsion phase; however, conventional microemulsion technology has a fatal weakness: because the particle size range of the microemulsion phase is in the range of 10-100nm, particles within this range will present blue light under light irradiation, but the nanoparticles within this range are very small, so they are very easy to agglomerate into large particles, causing the blue light of the product to disappear and become an ordinary white emulsion. The above solution of the present application can effectively avoid this problem and realize a product that can stably present a blue light without agglomeration. The above technical solution of the present application has developed a stable, blue-light bionic spray essence. The system has higher simplicity and versatility in operation, better stability, and better universality, and can be well applied to industrial production.

[0057] Furthermore, in some embodiments of the present application, the oil includes at least one of synthetic oil and / or vegetable oil.

[0058] Furthermore, in some embodiments of the present application, the synthetic oil comprises at least one of triethylhexanoin, caprylic / capric triglyceride, isohexadecane, isododecane, isononyl isononanoate or hydrogenated polyisobutene.

[0059] Illustratively, in some embodiments of the present application, the synthetic oil comprises: any one of tri(ethylhexanoin)glyceryl, caprylic / capric triglyceride, isohexadecane, isododecane, isononyl isononanoate or hydrogenated polyisobutene; or in some embodiments of the present application, the synthetic oil comprises: a mixture of tri(ethylhexanoin)glyceryl, caprylic / capric triglyceride, isohexadecane, isododecane, isononyl isononanoate and hydrogenated polyisobutene; the raw materials in the mixture are mixed in any proportion; or in some embodiments of the present application, the synthetic oil comprises: a mixture of tri(ethylhexanoin)glyceryl and caprylic / capric triglyceride; the raw materials in the mixture are mixed in any proportion; or in some embodiments of the present application, the synthetic oil comprises: a mixture of tri(ethylhexanoin)glyceryl, caprylic / capric triglyceride and isononyl isononanoate; the raw materials in the mixture are mixed in any proportion.

[0060] Furthermore, in some embodiments of the present application, the plant oil includes: at least one of squalane, cetearyl alcohol, hydrogenated polydecene, stearic acid, meadowfoam seed oil, jojoba seed oil, sunflower seed oil, olive oil, camellia seed oil, scutellaria oil or camellia seed oil.

[0061] For example, in some embodiments of the present application, the plant oil comprises any one of squalane, cetearyl alcohol, hydrogenated polydecene, stearic acid, meadowfoam seed oil, jojoba seed oil, sunflower seed oil, olive oil, camellia seed oil, scutellaria oil, and camellia seed oil; or in some embodiments of the present application, the plant oil comprises a mixture of squalane, cetearyl alcohol, hydrogenated polydecene, and stearic acid; and the raw materials in the mixture are mixed in any proportion. Or in some embodiments of the present application, the plant oil comprises a mixture of meadowfoam seed oil, jojoba seed oil, sunflower seed oil, olive oil, and camellia seed oil; and the raw materials in the mixture are mixed in any proportion.

[0062] Furthermore, in some embodiments of the present application, the emulsifier includes at least one of polyglyceryl-3 diisostearate, polyglyceryl-4 isostearate, polyglyceryl-10 myristate, or PPG-13-decyltetradecyl alcohol polyether-24.

[0063] For example, in some embodiments of the present application, the emulsifier includes any one of polyglyceryl-3 diisostearate, polyglyceryl-4 isostearate, polyglyceryl-10 myristate or PPG-13-decyltetradecyl alcohol polyether-24; or, in some embodiments of the present application, the emulsifier is a mixture of polyglyceryl-3 diisostearate and polyglyceryl-4 isostearate, and the raw materials in the mixture are mixed in any proportion. Or, in some embodiments of the present application, the emulsifier is a mixture of polyglyceryl-3 diisostearate, polyglyceryl-10 myristate, and PPG-13-decyltetradecyl alcohol polyether-24, and the raw materials in the mixture are mixed in any proportion. Or, in some embodiments of the present application, the emulsifier is a mixture of polyglyceryl-4 isostearate, polyglyceryl-10 myristate, and PPG-13-decyltetradecyl alcohol polyether-24, and the raw materials in the mixture are mixed in any proportion.

[0064] Furthermore, in some embodiments of the present application, the oil-soluble active ingredient includes: at least one of ceramides, astaxanthin, tocopherol, phytosterols, sphingolipids, phytosphingosine, tetraacetylphytosphingosine, glycosphingolipids, stearic acid, lecithin, hydrogenated lecithin, cholesterol, VC-IP, retinol, hydroxypinacolone retinoate or coenzyme Q-10.

[0065] For example, in some embodiments of the present application, the oil-soluble active ingredient includes any one of ceramides, astaxanthin, tocopherol, phytosterols, sphingolipids, phytosphingosine, tetraacetyl phytosphingosine, glycosphingolipids, stearic acid, lecithin, hydrogenated lecithin, cholesterol, VC-IP, retinol, hydroxypinacolone retinoate, or coenzyme Q-10; or in some embodiments of the present application, the oil-soluble active ingredient is a mixture of ceramides, astaxanthin, tocopherol, phytosterols, and sphingolipids, and the raw materials in the mixture are mixed in any proportion. Or in some embodiments of the present application, the oil-soluble active ingredient is a mixture of phytosphingosine, tetraacetyl phytosphingosine, glycosphingolipids, stearic acid, lecithin, hydrogenated lecithin, cholesterol, VC-IP, and retinol, and the raw materials in the mixture are mixed in any proportion.

[0066] Furthermore, in some embodiments of the present application, the ceramides include at least one of ceramide EOP, ceramide NP, or ceramide AP.

[0067] For example, in some embodiments of the present application, the ceramides include: any one of ceramide EOP, ceramide NP or ceramide AP; or in some embodiments of the present application, the ceramides are: a mixture of ceramide EOP, ceramide NP, and ceramide AP, and the raw materials in the mixture are mixed in any proportion; or in some embodiments of the present application, the ceramides are: a mixture of ceramide NP and ceramide AP, and the raw materials in the mixture are mixed in any proportion.

[0068] Furthermore, in some embodiments of the present application, the polyol includes at least one of glycerol, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90, or dipropylene glycol.

[0069] For example, in some embodiments of the present application, the polyol includes any one of glycerol, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90, or dipropylene glycol. Alternatively, in some embodiments of the present application, the polyol is a mixture of glycerol, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90, and dipropylene glycol; the individual ingredients in the mixture are mixed in any proportion. Alternatively, in some embodiments of the present application, the polyol is a mixture of glycerol, butylene glycol, panthenol, propylene glycol, and polyethylene glycol-8; the individual ingredients in the mixture are mixed in any proportion. Alternatively, in some embodiments of the present application, the polyol is a mixture of polyethylene glycol-90 and dipropylene glycol; the individual ingredients in the mixture are mixed in any proportion.

[0070] Furthermore, in some embodiments of the present application, the moisturizer includes at least one of glycerin, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90, or dipropylene glycol.

[0071] For example, in some embodiments of the present application, the moisturizing agent includes any one of glycerin, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90, or dipropylene glycol. Alternatively, in some embodiments of the present application, the moisturizing agent is a mixture of glycerin, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90, and dipropylene glycol; the individual ingredients in the mixture are mixed in any proportion. Alternatively, in some embodiments of the present application, the moisturizing agent is a mixture of glycerin, butylene glycol, panthenol, propylene glycol, and polyethylene glycol-8; the individual ingredients in the mixture are mixed in any proportion.

[0072] Furthermore, in some embodiments of the present application, the water-soluble active ingredient includes at least one of allantoin, dipotassium glycyrrhizate, niacinamide, soluble collagen, recombinant collagen, and polypeptides.

[0073] For example, in some embodiments of the present application, the water-soluble active ingredient includes any one of allantoin, dipotassium glycyrrhizate, niacinamide, soluble collagen, recombinant collagen, or polypeptides; or the water-soluble active ingredient includes a mixture of allantoin, dipotassium glycyrrhizate, niacinamide, soluble collagen, recombinant collagen, and polypeptides; the ingredients in the mixture are mixed in any proportion. Alternatively, in some embodiments of the present application, the water-soluble active ingredient is a mixture of allantoin, dipotassium glycyrrhizate, niacinamide, and soluble collagen; the ingredients in the mixture are mixed in any proportion.

[0074] Furthermore, the essence contains structural substances that mimic those found in human skin sebum, such as added fatty acids, ceramides, cholesterol, and other substances found in the skin; thus, it is a bionic cosmetic that is more suitable for skin use and is beneficial for skin care.

[0075] Furthermore, in some embodiments of the present application, in the oil phase, the mass ratio of the emulsifier to the oil is (2:3) to (1:1).

[0076] In the above technical solution, by setting the mass ratio of emulsifier to oil in the oil phase to (2:3) to (1:1), the essence can be formed into a stable, blue-light bionic spray essence; and no agglomeration will occur, which will not cause the blue light to disappear.

[0077] Illustratively, in the oil phase, the mass ratio of emulsifier to oil is 2:3, 7:10, 4:5, 9:10 or 1:1.

[0078] Furthermore, in some embodiments of the present application, the proportion of water in the oil phase is 4.47% to 4.5%.

[0079] In the above technical solution, by setting the proportion of water in the oil phase to 4.47% to 4.5%, the essence can be formed into a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0080] Illustratively, in some embodiments of the present application, the proportion of water in the oil phase is 4.47%, 4.48%, 4.49% or 4.5%.

[0081] Furthermore, in some embodiments of the present application, the proportion of oil-soluble active ingredients in the oil phase is 0.9% to 1.29%.

[0082] In the above technical solution, by setting the proportion of oil-soluble active ingredients in the oil phase to 0.9% to 1.29%, the essence can be formed into a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0083] Illustratively, in some embodiments of the present application, the proportion of oil-soluble active ingredients in the oil phase is 0.9%, 0.91%, 0.92%, 0.93%, 0.94%, 0.95%, 0.96%, 0.97%, 0.98%, 0.99%, 1%, 1.1%, 1.11%, 1.12%, 1.15%, 1.18%, 1.2%, 1.21%, 1.22%, 1.23%, 1.24%, 1.25%, 1.26%, 1.27%, 1.28% or 1.29%.

[0084] Furthermore, in some embodiments of the present application, the proportion of polyols in the oil phase is 67.3% to 70.5%.

[0085] In the above technical solution, by setting the proportion of polyols in the oil phase to 67.3% to 70.5%, the essence can be formed into a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0086] Illustratively, in some embodiments of the present application, the proportion of polyols in the oil phase is 67.3%, 67.5%, 67.8%, 68%, 68.2%, 68.5%, 68.6%, 68.8%, 69.2%, 69.5%, 69.8%, 70%, 70.1%, 70.2%, 70.3% or 70.5%.

[0087] Furthermore, in some embodiments of the present application, the proportion of fat in the oil phase is 13.47% to 14.1%.

[0088] In the above technical solution, by setting the proportion of oil in the oil phase to 13.47% to 14.1%, the essence can be formed into a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0089] Illustratively, in some embodiments of the present application, the proportion of fat in the oil phase is 13.47%, 13.48%, 13.49%, 13.5%, 13.51%, 13.52%, 13.55%, 13.58%, 13.6%, 13.62%, 13.65%, 13.68%, 13.7%, 13.75%, 13.8%, 13.85%, 13.9%, 13.95%, 14.0% or 14.1%.

[0090] Furthermore, in some embodiments of the present application, the proportion of the emulsifier in the oil phase is 9.4% to 13.5%.

[0091] In the above technical solution, by setting the proportion of emulsifier in the oil phase to 9.4% to 13.5%, the essence can be formed into a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0092] Illustratively, in some embodiments of the present application, the proportion of emulsifier in the oil phase is 9.4%, 9.45%, 9.5%, 9.55%, 9.6%, 9.65%, 9.7%, 9.75%, 9.8%, 9.9%, 9.95%, 10%, 10.5%, 10.8%, 11%, 11.5%, 11.8%, 12%, 12.5%, 12.8%, 13%, 13.2% or 13.5%.

[0093] Furthermore, in some embodiments of the present application, in the oil phase, the mass ratio of oil, oil-soluble active ingredient, polyol, emulsifier and water is: (0.3-0.6): (0.02-0.055): (1.5-3): (0.3-0.6): (0.1-0.2).

[0094] In the above technical solution, by setting the mass ratio of oil, oil-soluble active ingredients, polyols, emulsifiers and water in the oil phase to: (0.3-0.6): (0.02-0.055): (1.5-3): (0.3-0.6): (0.1-0.2), the essence can form a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0095] For example, in some embodiments of the present application, the mass ratio of oil, oil-soluble active ingredient, polyol, emulsifier and water is:

[0096] 0.3:0.02:1.5:0.3:0.1; or 0.35:0.025:1.6:0.35:0.15; or 0.4:0.03:2:0.4:0.16; or 0.5:0.04:2.5:0.5:0.18; or 0.6:0.05:2.8:0.55:0.19; or 0.58:0.055:3:0.6:0.2.

[0097] Furthermore, in some embodiments of the present application, the oil phase accounts for 2.22% to 4.455% of the essence in terms of mass percentage.

[0098] In the above technical solution, by setting the proportion of the oil phase in the essence to 2.22% to 4.455%, the essence can be formed into a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0099] Illustratively, in some embodiments of the present application, the oil phase accounts for 2.22%, 2.25%, 2.3%, 2.35%, 2.4%, 2.45%, 2.5%, 2.55%, 2.6%, 2.7%, 2.8%, 2.9%, 3%, 3.2%, 3.5%, 3.8%, 3.9%, 4%, 4.1%, 4.2%, 4.3%, 4.4% or 4.455% in the essence by mass percentage.

[0100] Furthermore, in some embodiments of the present application, in the aqueous phase, the mass ratio of the moisturizer to the water-soluble active ingredient is: (7-8):1.

[0101] In the above technical solution, by setting the mass ratio of moisturizer and water-soluble active substance in the aqueous phase to (7-8):1, the essence can be formed into a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0102] Illustratively, in some embodiments of the present application, in the aqueous phase, the mass ratio of the moisturizer to the water-soluble active ingredient is 7:1, 7.1:1, 7.2:1, 7.3:1, 7.4:1, 7.5:1, 7.6:1, 7.7:1, 7.8:1, 7.9:1 or 8:1.

[0103] Furthermore, in some embodiments of the present application, the essence comprises, by mass percentage: 2.22% to 4.455% of an oil phase; 2% to 10% of a moisturizer; 0.5% to 1% of a water-soluble active ingredient; and the balance water.

[0104] In the above technical solution, by setting the mass percentage, the essence includes: 2.22% to 4.455% of the oil phase; 2% to 10% of the moisturizer; 0.5% to 1% of the water-soluble active ingredient; and the balance water, so that the essence can form a stable, blue-light bionic spray essence; it will not agglomerate and will not cause the blue light to disappear.

[0105] For example, in some embodiments of the present application, the essence comprises, by weight percentage:

[0106] 2.22%, 2.23%, 2.24%, 2.25%, 2.26%, 2.27%, 2.28%, 2.29%, 2.3%, 2.35%, 2.36%, 2.4%, 2.5%, 2.8%, 3%, 3.5%, 3.8%, 4%, 4.1%, 4.2%, 4.3%, 4.4%, 4.45%, 4.455% or an oil phase in a range between any two of the foregoing values;

[0107] 2%, 2.1%, 2.2%, 2.5%, 3%, 3.5%, 3.8%, 4%, 4.2%, 4.5%, 4.8%, 5%, 5.5%, 6%, 6.5%, 7%, 7.5%, 8%, 8.5%, 9%, 9.5%, 10% or a range between any two of the foregoing values ​​of moisturizer;

[0108] 0.5%, 0.51%, 0.52%, 0.55%, 0.56%, 0.57%, 0.58%, 0.59%, 0.6%, 0.62%, 0.65%, 0.68%, 0.7%, 0.72%, 0.75%, 0.78%, 0.8%, 0.85%, 0.88%, 0.9%, 0.95%, 1% or a range between any two of the foregoing water-soluble active ingredients; and the balance water.

[0109] In other optional embodiments of the present application, the water phase further includes a preservative; and the oil phase further includes a fragrance.

[0110] Further optionally, in some embodiments of the present application, the preservative includes a combination of one or more of caprylyl glycol, 1,2-hexanediol, pentylene glycol, caprylhydroxamic acid, ethylhexylglycerin, etc.

[0111] Further optionally, in some embodiments of the present application, the fragrance includes a combination of one or more types of essences or essential oils.

[0112] Some embodiments of the present application provide a method for preparing a stable blue light bionic spray essence, comprising:

[0113] After mixing the various raw materials of the oil phase, heating to 65°C to 85°C to obtain a dissolved oil phase mixed raw material;

[0114] adding water dropwise to the dissolved oil phase mixed raw material to form a microemulsion phase;

[0115] The microemulsion phase is then added to the dissolved aqueous phase mixed materials.

[0116] Exemplarily, after mixing the various raw materials of the oil phase, the mixture is heated to 65°C, 66°C, 67°C, 68°C, 69°C, 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C or a temperature range between any two of the foregoing values ​​to obtain a dissolved oil phase mixed raw material.

[0117] In the above technical solution, water is added dropwise to the dissolved oil phase mixed raw materials to form a microemulsion phase; at this time, the oil phase forms a stable microemulsion phase with a blue light; further addition of water phase raw materials can further enhance the efficacy of the essence, but will not change the stable microemulsion phase already formed in the system itself, and only has a dilution effect; the essence as a whole still presents a stable microemulsion phase with a blue light, greatly enhancing the highlights of the product.

[0118] The preparation method of the present application has higher operational simplicity and versatility, better stability, and better universality, and can be well applied to industrial production.

[0119] In other embodiments of the present application, the preparation of the aqueous phase mixed raw material includes:

[0120] After mixing the various raw materials of the aqueous phase, the mixture is heated to 65°C to 85°C to obtain dissolved aqueous mixed raw materials.

[0121] Exemplarily, after mixing the various raw materials of the aqueous phase, the mixture is heated to 65°C, 66°C, 67°C, 68°C, 69°C, 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C or a temperature range between any two of the foregoing values ​​to obtain a dissolved aqueous mixed raw material.

[0122] In other embodiments of the present application, the microemulsion phase is added to the dissolved aqueous phase mixed raw materials, stirred and cooled to room temperature.

[0123] The features and performance of the present invention are further described in detail below with reference to the embodiments:

[0124] Example 1

[0125] A stable blue light bionic spray essence is provided, which is prepared according to the following steps:

[0126] In the oil phase, 0.1 g of polyglyceryl-3 isostearate, 0.2 g of PPG-13-decyltetradecyl alcohol polyether-24, 0.3 g of triethylhexanoin, 0.006 g of ceramides (ceramide EOP (0.002 g), ceramide NP (0.002 g), ceramide AP (0.002 g)), 0.003 g of cholesterol, 0.003 g of sphingolipids (phytosphingosine (0.001 g), methyl phytosphingosine (0.001 g), glycosphingolipids (0.001 g)), 0.003 g of stearic acid, 0.005 g of hydrogenated lecithin, 1.5 g of polyethylene glycol-8, and 0.001 g of flavor were weighed. After heating at 70°C to dissolve completely, 0.1 g of water was added dropwise to form a microemulsion phase. For the aqueous phase, weigh 5g of glycerol, 0.2g of niacinamide, 0.5g of soluble collagen, 0.8g of octylhydroxamic acid, and water (add enough water to make the total system 100g) and dissolve them completely at 70°C. Add the oil phase to the aqueous phase while stirring and allow to cool naturally to room temperature.

[0127] Repeat 3 times to obtain a stable, high-transparency, blue-light-emitting solution. Figure 1 shown.

[0128] Example 2

[0129] A stable blue light bionic spray essence is provided, which is prepared according to the following steps:

[0130] The oil phase was prepared by weighing 0.2g of polyglyceryl-4 isostearate, 0.4g of PPG-13-decyltetradecyl ether-24, 0.6g of triethylhexanoin, 0.01g of ceramide NP, 0.01g of cholesterol, 0.01g of phytosphingosine, 0.01g of lecithin, 3g of polyethylene glycol-8, and 0.002g of flavor. After complete dissolution at 70°C, 0.2g of water was added dropwise to form a microemulsion phase. The aqueous phase was prepared by weighing 5g of glycerin, 0.2g of niacinamide, 0.2g of allantoin, 0.2g of dipotassium glycyrrhizate, 0.5g of soluble collagen, 0.8g of octylhydroxamic acid, and water (the amount of water added was sufficient to bring the total system to 100g). The mixture was completely dissolved at 70°C. The oil phase was added to the aqueous phase under stirring and cooled to room temperature with natural stirring.

[0131] Repeat 3 times to obtain a stable medium-transparency blue solution. Figure 2 shown.

[0132] Example 3

[0133] A stable blue light bionic spray essence is provided, which is prepared according to the following steps:

[0134] In the oil phase, weigh 0.2g polyglyceryl-3 isostearate, 0.4g PPG-13-decyltetradecyl ether-24, 0.6g triethylhexanoin, 0.02g ceramide NP, 0.01g cholesterol, 0.01g phytosphingosine, 0.005g VC-IP, 0.01g lecithin, 3g polyethylene glycol-8, and 0.002g fragrance. Heat at 60°C until completely dissolved, then add 0.2g water dropwise to form a microemulsion. In the aqueous phase, weigh 5g panthenol, 0.2g niacinamide, 0.8g acetyl hexapeptide-8 aqueous solution, octylhydroxamic acid, and water (add enough water to bring the total volume to 100g). Dissolve completely at 60°C. Add the oil phase to the aqueous phase with stirring, and cool naturally to room temperature with stirring.

[0135] Repeat 3 times to obtain a stable, high-transparency, blue-light-emitting solution. Figure 3 shown.

[0136] Example 4

[0137] A stable blue light bionic spray essence is provided, which is prepared according to the following steps:

[0138] The oil phase weighs 0.1g polyglycerol-10 myristate, 0.3g PPG-13-decyltetradecyl polyether-24, 0.6g triethylhexanoate, 0.02g ceramide NP, 0.01g cholesterol, 0.01g phytosphingosine, 0.005g astaxanthin, 0.01g lecithin, 3g polyethylene glycol-8, and 0.002g fragrance. After heating at 60°C to dissolve completely, 0.2g water is added dropwise to form a microemulsion phase. The aqueous phase weighs 5g propylene glycol, 0.2g allantoin, 0.1g recombinant collagen, 0.8g octylhydroxamic acid, and water (the amount of water added is sufficient to make the entire system reach 100g). Dissolve completely at 60°C. Add the oil phase to the aqueous phase under stirring and cool to room temperature with natural stirring.

[0139] Repeat 3 times to obtain a stable, high-transparency, blue-light-emitting solution. Figure 4 shown.

[0140] Comparative Example 1

[0141] Provided is an essence, prepared according to the following steps:

[0142] For the oil phase, weigh 0.3g Tween-60, 0.3g triethylhexanoin, 0.005g ceramide NP, 0.005g cholesterol, 0.005g phytosphingosine, 0.005g lecithin, 1.5g polyethylene glycol-8, and 0.001g fragrance. Heat at 70°C until completely dissolved, then add 0.1g water dropwise to form a microemulsion. For the aqueous phase, weigh 5g glycerin, 0.01g sodium hyaluronate, 0.2g niacinamide, 0.5g soluble collagen, 0.8g octylhydroxamic acid, and water (add enough water to bring the total system to 100g). Dissolve completely at 70°C. Add the oil phase to the aqueous phase while stirring, and cool naturally to room temperature with stirring.

[0143] Repeat 3 times to obtain a white emulsion. Figure 5 shown.

[0144] Comparative Example 2

[0145] Provided is an essence, prepared according to the following steps:

[0146] For the oil phase, weigh 0.6g Tween-60, 0.3g triethylhexanoin, 0.005g ceramide NP, 0.005g cholesterol, 0.005g phytosphingosine, 0.005g lecithin, 1.5g polyethylene glycol-8, and 0.001g fragrance. Heat at 70°C until completely dissolved, then add 0.1g water dropwise to form a microemulsion. For the aqueous phase, weigh 5g panthenol, 0.02g sodium hyaluronate, 0.2g allantoin, 0.5g acetyl hexapeptide-8, 0.8g octylhydroxamic acid, and water (add enough water to bring the total system to 100g). Dissolve completely at 70°C. Add the oil phase to the aqueous phase while stirring, and cool naturally to room temperature with stirring.

[0147] Repeat 3 times to obtain a white emulsion. Figure 6 shown.

[0148] Comparative Example 3

[0149] Provided is an essence, which is prepared according to conventional steps in the prior art: 8g of PEG-60 hydrogenated castor oil, 3g of steareth-20, 2g of polyglyceryl-2 diisostearate, 10g of glyceryl triethylhexanoate, 4g of squalane, and 4g of vitamin E are mixed and heated to 70°C for complete dissolution to prepare phase A;

[0150] Heat 20 g of water to 85°C to prepare phase B;

[0151] Add phase A to phase B while stirring rapidly, and continue heating to above 90°C to obtain phase C.

[0152] Phase C was poured into the rapidly stirred remaining aqueous phase, and the mixture was cooled while stirring. 8 g of glycerol, 7 g of 1,3-butanediol, and a preservative were added in sequence, and stirred evenly to prepare a white emulsion. A blue-light emulsion could not be obtained.

[0153] The process was repeated three times, resulting in a white emulsion, and no blue-tinted emulsion could be achieved. This shows that the conventional system containing PEG-60 hydrogenated castor oil has very stringent requirements for the formation of a microemulsion phase, is difficult to form stably, and is highly accidental. It cannot be universally applied in industry and has no practical application value.

[0154] 1. The blue light stability of the essences obtained in various examples and comparative examples was tested.

[0155] Test method: The essences prepared in various examples and comparative examples were packaged in sample bottles, placed under room temperature, light, 45°C, -18°C, and 4°C conditions, and stability was observed regularly.

[0156] The test results are shown in the attached manual. Figure 1 ~Attachment Figure 7 ; and Tables 1 to 4.

[0157] from Figure 1-Figure 7 From the comparison, it can be seen that Examples 1-4 formed a blue light transparent solution. In Example 4, the color of the overall paste was changed due to the color of astaxanthin, but it still had a blue light effect.

[0158] Table 1 Stability study data of Example 1

[0159]

[0160] Table 2: Stability study data of Example 2

[0161]

[0162] Table 3: Stability study data of Example 3

[0163]

[0164] Table 4: Stability study data of Example 4

[0165]

[0166] 2. The spray effects of the essences obtained in the various embodiments and comparative examples were tested.

[0167] Test method: Put the examples and comparative examples into a superfine spray bottle and demonstrate the spray effect

[0168] The test results are shown in the attached manual. Figure 8 .

[0169] Figure 8 The spray effects of the embodiments and comparative examples are shown. It can be seen from the figure that embodiments 1-4 have good spray effects, while the spray effects of comparative examples 1-2 are relatively poor because sodium hyaluronate is added to the aqueous phase, which makes it impossible to achieve a spray effect. Comparative example 3 also exhibits a relatively good spray effect because sodium hyaluronate is not added. Therefore, polysaccharides with specific properties such as sodium hyaluronate are not suitable for aqueous spray products.

[0170] In summary, the solution of the embodiment of the present application provides an aqueous product that exhibits a stable blue light state and can form a fine spray; the product will not agglomerate. Therefore, it can be seen that the solution of the present application has developed a stable, blue light bionic spray essence.

[0171] The above description is merely a preferred embodiment of the present application and is not intended to limit the present application. Various modifications and variations are possible for those skilled in the art. Any modifications, equivalent substitutions, or improvements made within the spirit and principles of the present application shall be included within the scope of protection of the present application.

Claims

1. A stable blue light bionic spray essence, characterized in that: The essence is composed of the following components in percentage by mass: 2.22% to 4.455% of an oil phase; 2% to 10% of a moisturizer; 0.5% to 1% of a water-soluble active ingredient; and the balance water; The essence is a highly transparent blue solution; The oil phase is a microemulsion phase; The oil phase includes: oil, oil-soluble active substances, polyols, emulsifiers and water; The aqueous phase includes: humectants, water-soluble active ingredients and water; The essence presents a blue light state, and the essence can be in a spray form; The emulsifier is a mixture of polyglyceryl-3 isostearate and PPG-13-decyltetradecyl alcohol polyether-24; or the emulsifier is a mixture of polyglyceryl-4 isostearate and PPG-13-decyltetradecyl alcohol polyether-24; or the emulsifier is a mixture of polyglyceryl-10 myristate and PPG-13-decyltetradecyl alcohol polyether-24; The oil-soluble active ingredient is a mixture of ceramides, cholesterol, sphingolipids, stearic acid and hydrogenated lecithin; or the oil-soluble active ingredient is a mixture of ceramides, cholesterol, sphingolipids and lecithin; The water-soluble active substance is a mixture of nicotinamide and soluble collagen; or the water-soluble active substance is a mixture of nicotinamide, allantoin, dipotassium glycyrrhizate and soluble collagen; or the water-soluble active substance is a mixture of nicotinamide and polypeptide; or the water-soluble active substance is a mixture of allantoin and recombinant collagen; The moisturizing agent is glycerin; or the moisturizing agent is panthenol; or the moisturizing agent is propylene glycol.

2. The stable blue light bionic spray essence according to claim 1, characterized in that: The oil comprises at least one of synthetic oil and / or vegetable oil.

3. The stable blue light bionic spray essence according to claim 2, characterized in that: The synthetic oil comprises at least one of tri(ethylhexanoin)glyceryl, caprylic / capric triglyceride, isohexadecane, isododecane, isononyl isononanoate or hydrogenated polyisobutene.

4. The stable blue light bionic spray essence according to claim 2, characterized in that: The plant oil comprises at least one of squalane, cetearyl alcohol, hydrogenated polydecene, stearic acid, meadowfoam seed oil, jojoba seed oil, sunflower seed oil, olive oil, camellia seed oil, scutellaria oil or camellia seed oil.

5. The stable blue light bionic spray essence according to claim 1, characterized in that: The ceramides include at least one of ceramide EOP, ceramide NP, and ceramide AP.

6. The stable blue light bionic spray essence according to claim 1, characterized in that: The polyol includes at least one of glycerin, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90 or dipropylene glycol.

7. The stable blue light bionic spray essence according to any one of claims 1 to 6, characterized in that: In the oil phase, the mass ratio of the emulsifier to the oil is (2:3) to (1:1).

8. The stable blue light bionic spray essence according to any one of claims 1 to 6, characterized in that: The proportion of water in the oil phase is 4.47% to 4.5%.

9. The stable blue light bionic spray essence according to any one of claims 1 to 6, characterized in that: The proportion of the oil-soluble active ingredient in the oil phase is 0.9% to 1.29%.

10. The stable blue light bionic spray essence according to any one of claims 1 to 6, characterized in that: The proportion of the polyol in the oil phase is 67.3% to 70.5%.

11. The stable blue light bionic spray essence according to any one of claims 1 to 6, characterized in that: The proportion of the oil in the oil phase is 13.47% to 14.1%.

12. The stable blue light bionic spray essence according to any one of claims 1 to 6, characterized in that: The proportion of the emulsifier in the oil phase is 9.4% to 13.5%.

13. The stable blue light bionic spray essence according to any one of claims 1 to 6, characterized in that: In the oil phase, the mass ratio of the oil, the oil-soluble active ingredient, the polyol, the emulsifier and the water is: (0.3-0.6): (0.02-0.055): (1.5-3): (0.3-0.6): (0.1-0.2).

14. The stable blue light bionic spray essence according to any one of claims 1 to 6, characterized in that: In terms of mass percentage, the oil phase accounts for 2.22% to 4.455% of the essence.

15. The stable blue light bionic spray essence according to any one of claims 1 to 6, characterized in that: In the aqueous phase, the mass ratio of the moisturizer to the water-soluble active ingredient is (7-8):

1.

16. The method for preparing the stable blue-light bionic spray essence according to any one of claims 1 to 15, characterized in that: include: After mixing the various raw materials of the oil phase, heat to 65°C~85°C to obtain a dissolved oil phase mixed raw material; adding water dropwise to the dissolved oil phase mixed raw material to form a microemulsion phase; The microemulsion phase is then added to the dissolved aqueous phase mixed stock.

17. The method for preparing the stable blue light bionic spray essence according to claim 16, characterized in that: include: The preparation of the aqueous phase mixed raw material comprises: After mixing the various raw materials of the aqueous phase, heat to 65°C to 85°C to obtain dissolved aqueous phase mixed raw materials.

18. The method for preparing the stable blue light bionic spray essence according to claim 17, characterized in that: include: The microemulsion phase was added to the dissolved aqueous phase mixed raw materials, also stirred and allowed to cool to room temperature.

Images